A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer.
Arima S, Shimizu K, Okamoto T, Toki M, Suzuki Y, Okano N, Naruge D, Kawai K, Kobayashi T, Kasuga A, Kitamura H, Takasu A, Nagashima F, Sugiyama M, Furuse J.
Arima S, et al. Among authors: kitamura h.
Anticancer Res. 2017 Feb;37(2):909-914. doi: 10.21873/anticanres.11398.
Anticancer Res. 2017.
PMID: 28179351
Clinical Trial.